网上乱贴
The Federal Food, Drug, and Cosmetic Act and FDA regulations permit the submission of ANDAs for drug products that differ in dosage form compared to a listed drug. 21 U.S.C. 5 355(j) (2) (C); 21 C.F.R. $9 314.93, 5.10. FDA has recently approved a number of ANDA suitability petitions seeking comparable dosage form change from tablet to orally disintegrating tablet.
最后编辑于 2009-05-25 · 浏览 1.0 万